A study to test how well healthy people tolerate spesolimab when given in 2 different ways.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510448-20-00

Acronym

1368-0151

Enrollment

Registered

2024-07-17

Start date

2024-07-30

Completion date

2025-02-04

Last updated

2024-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026